Skip to content

High Protein Dairy Products and Resistance Exercise in the Elderly

No-Whey: High Protein Dairy and Resistance Exercise for the Improvement of Body Composition and Muscle Function in the Elderly

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06412302
Enrollment
18
Registered
2024-05-14
Start date
2023-06-01
Completion date
2024-01-12
Last updated
2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dairy Products, Older Adults, Resistance Training, Whey Protein

Brief summary

Protein supplementation is one of the main recommendations for regular endurance physical exercise (RT). In older people, the need for protein increases particularly in the face of physiological and pathophysiological changes associated with the loss of muscle tissue and function, so protein intake becomes more relevant in this population. Fermented dairy products such as yogurt, and especially those with an extra protein content, have increased their popularity and consumption in the national market. Their nutritional composition is of particular interest, given their amino acid profile and in particular their high Leucine content, which could be compared with the classic protein supplements recommended for muscle gain and recovery. Objective: To analyze the effect on body composition, lipid profile, physical condition and muscle functionality induced by the intake of high protein yogurts versus Whey protein together with a muscular resistance program in elderly people. Hypothesis: The intake of high protein yogurts will lead to equal or greater gains in muscle mass, physical condition and functionality than those obtained with the intake of Whey protein together with resistance training in elderly people.Methodology: 16 healthy, lactose intolerant free, older (60-75 years old) subjects will be recruited to perform 8 weeks of muscular resistance training (RT) 3 times per week, who will be randomly supplemented with high protein yogurt (PY) or Whey protein (WP). At baseline and at the end of the intervention, body composition will be assessed by DEXA, muscle strength, maximal oxygen consumption and lipid profile. Expected Results: The YPRT group is expected to achieve similar or greater increases in muscle strength, fat-free mass, lipid profile and decrease in fat mass than the WP group.

Interventions

OTHERWhey Protein+Resistance Training

WP group received 25g protein on one scoop of Whey Protein Isolate (Iso100 Dymatize) with 8 weeks of resistance training 3 days a week.

OTHERHigh protein yogurt+Resistance Training

PY group received 24.6g protein on two High Protein yogurts (Lonco Leche) with 8 weeks of resistance training 3 days a week.

Sponsors

Instituto de Nutrición y Tecnología de los Alimentos
CollaboratorOTHER
Geroscience Center for Brain Health and Metabolism (Gero)
CollaboratorOTHER_GOV
Motion Health and Performance Center
CollaboratorUNKNOWN
Universidad de O´Higgins
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

The PY group will be provided with two yogurts and 50 of water (220g per serving, containing 24.6g protein, 1.4g fat, and 16.6 carbohydrates), while the WP will be provided with a shake with water (25g per serving containing; 25g protein, 0g fat, and 1g carbohydrates, dissolved in water), immediately after the exercise session which a trainer will monitor. Both groups will submit to a resistance training group every 8 weeks.

Eligibility

Sex/Gender
ALL
Age
60 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* \>60 years * Less than 1 hour of exercise a week

Exclusion criteria

* Lactose Intolerant * Smoking * Type 1 or 2 Diabetes * Alcohol intake * Currently taking protein, high protein yogurts, creatine, HMB or any other supplement that aims to improve muscle mass

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the intestinal microbiotaFrom Baseline, up to 56 daysFecal microbiota analysis based on the 16S ribosomal RNA (rRNA) sequencing pre- and post-dietary intervention.
Aerobic CapacityFrom Baseline, up to 56 daysMaximal Oxygen Consumption determine by the volume of oxygen (L/min)obtained on a incremental test
Resting Metabolic RateFrom Baseline, up to 56 daysDetermine by indirect calorimetry (kcal/d)
Body CompositionFrom Baseline, up to 56 daysChanges in weight, total fat mass, total skeletal muscle mass, segmental fat and muscle mass
Blood LipidsFrom Baseline, up to 56 daysChanges on Serum Triglycerides, Total Cholesterol, and High Density Cholesterol (mmol/L)
Muscle StrengthFrom Baseline, up to 56 daysDetermine by Isometric mid-tight pull (Newton, N)
HandgripFrom Baseline, up to 56 daysHandgrip Strength measured on left and right hand (kg)
Time Up and GoFrom Baseline, up to 56 daysLength of time from sitting-walk-sit (seconds)
Isokinetic Muscle StrengthFrom Baseline, up to 56 daysMaximal peak torque from left and right quadriceps and hamstrings (N/m)

Secondary

MeasureTime frameDescription
Evaluation of liver characteristics profileFrom Baseline, up to 56 daysUric acid, BUN, Albumin, Creatinine aspartate aminotransferase (ASAT), alanine aminotransferase (ALAT), gamma-glutamyltransferase (GGT) after every intervention and wash-out in plasma (mmol/L).
Food ConsumptionFrom Baseline, up to 56 days24h food recall

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026